Core Functions:The cellular imaging core will provide three major services to all four of the projects in this PPG includingcomprehensive: 1) functional analysis of cardiac cells in wild-type and genetically modified mice 2) ultrastructuralanalysis of cardiac cells in wild-type and genetically modified mice and 3) evaluation of apoptosis inmyocardial tissue.Functional cellular analysis includes:A) Enzymatic isolation and electrical-field stimulated culture of murine adult ventricular cardiomyocytes(VCs)B) Assessment of in vitro contractile function of VCs using a digitalized video-edge detection systemC) Analysis of in vitro cellular calcium (Ca2+) transients in VCs using the fluorescent calcium indicatorFURA2-AM.Ultra-structural cellular analysis includes:A) Immunofluorescent confocal microscopy of VCsB) Immunofluorescent and immunohistological microscopic analysis of myocardial tissueC) Epifluorescent analysis of VC morphologyApoptosis evaluation includes:A) Terminal deoxynucleotidyl-transferase mediated dUTP nick end (TUNEL) labeling and related imaging inmyocardial sectionsB) Caspase-3 activity in myocardial extractsC) Hairpin 1 (apoptosis) and Hairpin 2 (necrosis)D) Cardiac Myosin Heavy Chain imagingThe laboratories of the Core Co-Directors have considerable experience in a wide-ranging array ofmethodologies for functional and ultra-structural cellular imaging. In particular, isolation and maintenance ofhigh-quality murine VCs is a crucial prerequisite for subsequent functional and ultra-structural analysis. Anenzymatic isolation procedure yielding more than 90% viable VCs has been established by Core Co-Directorsand is combined with a low-frequent field-stimulated culture system preventing functional and structuraldedifferentiation such as the disintegration of the T-tubular system with subsequent loss of cellularexcitability. This innovative approach will enable us to investigate VCs from the same heart in a functionaland ultra-structural manner.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL091799-01
Application #
7488129
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2008-05-01
Project End
2013-03-31
Budget Start
2008-05-01
Budget End
2009-03-31
Support Year
1
Fiscal Year
2008
Total Cost
$211,836
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
de Lucia, Claudio; Gambino, Giuseppina; Petraglia, Laura et al. (2018) Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure. Circ Heart Fail 11:e004153
Tahrir, Farzaneh G; Shanmughapriya, Santhanam; Ahooyi, Taha Mohseni et al. (2018) Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes. J Cell Physiol 233:748-758
Myers, Valerie D; McClung, Joseph M; Wang, JuFang et al. (2018) The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease. JACC Basic Transl Sci 3:122-131
Myers, Valerie D; Tomar, Dhanendra; Madesh, Muniswamy et al. (2018) Haplo-insufficiency of Bcl2-associated athanogene 3 in mice results in progressive left ventricular dysfunction, ?-adrenergic insensitivity, and increased apoptosis. J Cell Physiol 233:6319-6326
Borghetti, Giulia; von Lewinski, Dirk; Eaton, Deborah M et al. (2018) Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control. Front Physiol 9:1514
Grisanti, Laurel A; Schumacher, Sarah M; Tilley, Douglas G et al. (2018) Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic Transl Sci 3:550-562
de Lucia, Claudio; Eguchi, Akito; Koch, Walter J (2018) New Insights in Cardiac ?-Adrenergic Signaling During Heart Failure and Aging. Front Pharmacol 9:904
Grisanti, Laurel A; Thomas, Toby P; Carter, Rhonda L et al. (2018) Pepducin-mediated cardioprotection via ?-arrestin-biased ?2-adrenergic receptor-specific signaling. Theranostics 8:4664-4678
Cannavo, Alessandro; Koch, Walter J (2018) GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cell Signal 41:33-40
Yeh, Szu-Tsen; Zambrano, Cristina M; Koch, Walter J et al. (2018) PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro. J Biol Chem 293:8056-8064

Showing the most recent 10 out of 163 publications